1. Introduction {#sec1-molecules-22-00842}
===============

The genus *Callicarpa* belongs to the family Verbenaceae, with about 190 species widely distributed throughout the tropical and subtropical regions of Asia and Oceanica and parts of America \[[@B1-molecules-22-00842],[@B2-molecules-22-00842]\]. Many *Callicarpa* species are used in Chinese folk medicine for various indications \[[@B2-molecules-22-00842]\]. Compounds that represent a variety of different classes have been reported, including diterpenoids, triterpenoids, flavonoids, phenolic acids, volatile oils and so on \[[@B2-molecules-22-00842],[@B3-molecules-22-00842],[@B4-molecules-22-00842],[@B5-molecules-22-00842]\]. Currently, *Callicarpa macrophylla* Vahl. is used as a folk medicine in China's Yunnan Province, were the root, the stem, and the leaves are all used in medicine. *Callicarpa macrophylla* Vahl. has a bitter taste, slightly acrid and flat, with clinical actions that eliminate stasis to activate blood circulation and stop bleeding, and it also has detumescence and analgesic actions \[[@B6-molecules-22-00842]\].

Past phytochemical studies on *Callicarpa macrophylla* Vahl. Have revealed the presence of pentacyclic triterpenes, sterols \[[@B6-molecules-22-00842]\], and diterpenes \[[@B7-molecules-22-00842],[@B8-molecules-22-00842]\]. Additionally, some of the literature has reported that diterpenoid compounds in *Callicarpa* showed potent anti-inflammatory activities \[[@B9-molecules-22-00842],[@B10-molecules-22-00842]\]. Being interested in finding more biologically active substances from this folk medicine, we further undertook an investigation to explore its phytochemical composition. As a result, three new abietane-type diterpenoids 1--3, named callicapoic acids M 3--5 ([Figure 1](#molecules-22-00842-f001){ref-type="fig"}) were isolated from the dried whole herb of *Callicarpa macrophylla* Vahl. This paper deals with their structural elucidation and anti-inflammatory activity against RAW 264.7 macrophage cells line determined by means of MTT assays.

2. Results and Discussion {#sec2-molecules-22-00842}
=========================

Compound **1** (callicapoic acid M3), obtained as white amorphous powder (from acetone), gave the molecular formula C~20~H~26~O~3~, as deduced from the HR-ESI-MS peak at *m*/*z* 315.1958 \[M + H\]^+^. Its IR spectrum showed hydroxyl (3401 cm^−1^) and carboxyl group (1700 cm^−1^) absorptions, and the UV spectrum showed the presence of an aromatic moiety with maxima at 211 and 250 nm. The ^1^H-NMR spectrum of **1** ([Table 1](#molecules-22-00842-t001){ref-type="table"}) revealed an isopropenyl group \[δ~H~ 2.11 (3H, s), 5.02 (1H, s), 5.32 (1H, s)\], one methyl group \[δ~H~ 1.16 (3H, s)\], a pair of methylene protons \[δ~H~ 3.48, 4.16 (each 1H, d, *J* = 5.9 Hz)\] bearing an oxygen function, and a 1,2,4 substitution pattern for the aromatic C ring was easily recognized from inspection of other ^1^H-NMR signals \[δ~H~ 7.21, 8.25 (each 1H, d, *J* = 8.2 Hz) and 7.12 (1H, s)\] and of other C ring aromatized compounds \[[@B11-molecules-22-00842],[@B12-molecules-22-00842],[@B13-molecules-22-00842]\].

The ^13^C-NMR spectrum of **1** ([Table 1](#molecules-22-00842-t001){ref-type="table"}) confirmed the presence of a benzene ring, in addition to two methyl, six methylene, one methine, one carboxyl, two olefinic carbon signals, and two quaternary carbon signals, as well as an additional methylene carbon (δ~C~ 71.4) attached to an oxygen function. From this information, compound **1** was inferred to be an abietane-type diterpene by comparison with the literature identification data of similar typical abietanes, like the triptobenzenes A--K isolated from *T. wilfordiivar. Regelii* \[[@B14-molecules-22-00842]\] and *T. hypoglaucum* \[[@B15-molecules-22-00842]\].

In the HMBC spectrum of **1** ([Figure 2](#molecules-22-00842-f002){ref-type="fig"}), the methyl proton signal (δ~H~ 2.11) of the isopropenyl group correlated with the carbon signals at δ~C~ 138.3 (C-13), 142.9 (C-15), and 111.7 (C-16), and the proton signal δ~H~ 8.25 (H-12) correlated with signals at δ~C~ 142.9 (C-15), 147.2 (C-9), and 126.0 (C-14). In turn, the proton signal δ~H~ 7.12 (H-14) correlated with the signals at δ~C~ 142.9 (C-15), 147.2 (C-9), 123.1 (C-12), and 31.6 (C-7). From these observations, the location of the isopropenyl group at C-13 was inferred. Further, the proton signals at δ~H~ 3.48, 4.16 (H~2~-18) correlated with the signals at δ~C~ 32.0 (C-3), 49.9 (C-4), 47.7 (C-5), and 181.1 (C-19), implied the hydroxyl group in **1** could be assigned to position C-18. In the NOESY spectrum, the proton signals at δ~H~ 3.48, 4.16 (H~2~-18) showed correlations with the proton signal at δ~H~ 1.69 (H-5), and showed no correlation with the methyl proton signals at δ~H~ 1.16 (H~3~-20). Thus, the configuration of the hydroxy methylene at C-4 was confirmed to be α, and the methyl at C-10 was confirmed to be β. The above evidence allowed identification of compound **1** as 18-hydroxy-8,11,13,15-abietatetraen-19-oic acid.

Callicapoic acid M4 (**2**) was isolated as a white amorphous powder (from acetone). Its molecular formula was established as C~20~H~28~O~3~ by the HR-ESI-MS signal at *m*/*z* 339.1927 \[M + Na\]^+^. The 1D ([Table 1](#molecules-22-00842-t001){ref-type="table"}) and 2D NMR data of **2** showed the presence of an abietane-type diterpene skeleton, which indicated its structure be similar to that of **1**, except for a side chain isopropyl group, suggested by the appearance of characteristic resonances at δ~H~ 1.21 (3H, s), 1.22 (3H, s), and 2.82 (1H, m); and δ~C~ 24.0, 24.0 and 33.4. In the HMBC spectrum ([Figure 2](#molecules-22-00842-f002){ref-type="fig"}), the methine proton signal (δ~H~ 2.82) of the isopropyl group correlated with C-12 (δ 124.1), C-13 (δ 145.8) and C-14 (δ 126.8). In turn, the proton signals at δ~H~ 6.99 (H-12) and 6.87 (H-14) correlated with the methine signal at δ~C~ 33.4 (C-15). From these observations, the location of the side chain of isopropyl group at C-13 was inferred. The relative configuration of **2** was established by a NOESY experiment, and 4-CH~2~OH, 10-CH~3~ were found to be the same as those of **1**. Accordingly, compound **2** was identified as 18-hydroxy-8,11,13-abietatetraen-19-oic acid ([Figure 1](#molecules-22-00842-f001){ref-type="fig"}) and named callicapoic acid M4 (**2**). Compound **2** is the C-4 epimer of a known compound described in the literature \[[@B16-molecules-22-00842]\].

Callicapoic acid M5 (**3**), a white amorphous powder, possessed a molecular formula of C~21~H~26~O~5~ according to its HR-ESI-MS signal at *m*/*z* 359.1873 \[M + H\]^+^. The 1D ([Table 1](#molecules-22-00842-t001){ref-type="table"}) and 2D NMR data of **3** clearly revealed the presence of an abietane-type diterpene skeleton, and also indicated its structure be similar to that of **1** except for the two side chains. The differences between them were that the isopropenyl was replaced by an acetyl at C-13, and the hydroxyl at C-18 was acetylated. The first difference had characteristic resonances at δ~H~ 2.56 (3H, s); and δ~C~ 26.7, 198.3 which implied the presence of an acetyl, while HMBC correlations from protons of methyl at δ~H~ 2.56 to C-13 (δ 134.8) suggested that acetyl was connected to C-13. The second difference in the characteristic resonances at δ~H~ 2.06 (3H, s); and δ~C~ 20.9, 171.0 also implied the presence of an acetyl, HMBC correlations from the methylene protons at δ~H~ 4.10 and 4.49 (H~2~-18) to C-21 (δ 171.0) suggested that the C-18 hydroxyl was acetylated. The relative configuration of 10-CH~3~ was established as β-oriented, 4-CH~2~O- was confirmed to be α-oriented by a NOESY experiment, the same as those of **1** and **2**. Therefore, compound **3** was thus identified as 15-acetyl-19-carbethoxy-8,11,13-abietatetraen-18-oic acid ([Figure 1](#molecules-22-00842-f001){ref-type="fig"}).

Nitric oxide (NO) plays an important role in the inflammatory process \[[@B17-molecules-22-00842]\].The inhibition of NO release may be effective as a therapeutic agent in the inflammatory diseases \[[@B18-molecules-22-00842]\]. Therefore, compounds **1** to **3** were tested for the inhibitory activity against the production of NO in RAW 264.7 stimulated by lipopolysaccharide (LPS). The anti-inflammatory assay was carried out according to the procedure described previously. The results were summarized in [Table 2](#molecules-22-00842-t002){ref-type="table"} and indicated that all the three compounds could significantly inhibit NO introduction in LPS-activated RAW 264.7 macrophage cells.

3. Experimental {#sec3-molecules-22-00842}
===============

3.1. General Procedures {#sec3dot1-molecules-22-00842}
-----------------------

Optical rotations were determined on a 241 MC polarimeter (Perkin-Elmer, Waltham, MA, USA). UV spectra were obtained on Perkin Elmer Lambda 35 UV/VIS Spectrometer. IR spectra were recorded on a IFS 55 spectrophotometer (Bruker, Billerica, MA, USA). The NMR data were recorded on a Bruker AV-600 spectrometer. The HR-ESI-MS data were obtained on a LCT Premier XE time-of-flying mass spectrometer (Waters, Milford, MA, USA). Chromatography was performed on silica gel (200--300 mesh; Qingdao Marine Chemical Group Co. Ltd., Qingdao, China) and ODS (30--50 μm; Tianjin Mical Reagent Co., Tianjin, China). Prep. HPLC was performed on a system comprised of a L-7110 pump and a L-7420 UV spectrophotometric detector set at 203 nm (Hitachi, Tokyo, Japan). A YMC C~18~ reversed-phase column (5 μm, 10 × 250 mm; flow rate 2.0 mL/min) was used.

3.2. Plant Material {#sec3dot2-molecules-22-00842}
-------------------

Dried whole herb of *Callicarpa macrophylla* Vahl. were collected in Yunnan Province, China, in August 2011 and identified by Jincai Lu (School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University). A voucher specimen (No. 20110801) was deposited in the Research Department of Natural Medicine, Shenyang Pharmaceutical University.

3.3. Exaction and Isolation {#sec3dot3-molecules-22-00842}
---------------------------

Dried whole herb of *Callicarpa macrophylla* Vahl. (4.5 kg) was extracted with 50 L 95% EtOH (×3) under reflux conditions for three hours to give a crude extract, which was suspended in H~2~O and successively extracted with petroleum ether (PE), CHCl~3~ and EtOAc to yield a PE-soluble fraction (17.2 g), a CHCl~3~-soluble fraction (261.7 g) and an EtOAc-soluble fraction (55.3 g). A part of the CHCl~3~-soluble fraction (70 g) was subjected to column chromatography (CC, silica gel, gradient of PE-acetone 100:1--0:100) to afford 46 fractions (numbered 1--46). Fractions 30--36 (5.2 g) were separated by CC (ODS, MeCN--H~2~O 30:70, MeCN--H~2~O 40:60) to yield fraction ods40, which was further subjected by semi-preparative reversed-phase HPLC (MeOH/H~2~O with 0.2% HCO~2~H, (62:38, *v*/*v*) as mobile phase, flow rate 3.0 mL/min, wavelength 203 nm), to afford **1** (10.8 mg), **2** (16.4 mg) and **3** (11.2 mg), respectively.

*Callicapoic Acid M3* (**1**). White amorphous powder, \[α$\rbrack_{D}^{20}$ +57.0 (MeOH, *c* 0.37). UV (MeOH) λ~max~: 211, 250 nm. IR (KBr) ν~max~ (cm^−1^): 3401, 2930, 1700 and 1561. ^1^H-NMR and ^13^C-NMR spectral data are shown in [Table 1](#molecules-22-00842-t001){ref-type="table"}. HR-ESI-MS *m*/*z*: 315.1958 (C~20~H~27~O~3~^+^, \[M + H\]^+^, calc. 315.1960).

*Callicapoic Acid M4* (**2**). White amorphous powder, \[α$\rbrack_{D}^{20}$ +22.2 (MeOH, *c* 0.10). UV (MeOH) λ~max~: 205, 266 nm. IR (KBr) ν~max~ (cm^−1^): 3426, 2923, 1630 and 1384. ^1^H-NMR and ^13^C-NMR spectral data are shown in [Table 1](#molecules-22-00842-t001){ref-type="table"}. HR-ESI-MS *m*/*z*: 339.1927 (C~20~H~28~NaO~3~^+^, \[M + Na\]^+^, calc. 339.1936).

*Callicapoic acid M5* (**3**). White amorphous powder, \[α$\rbrack_{D}^{20}$ +41.2 (MeOH, *c* 0.24). UV (MeOH) λ~max~: 209, 258 nm. IR (KBr) ν~max~ (cm^−1^): 3411, 2927, 1723, 1658 and 1351. ^1^H- and ^13^C-NMR spectral data are shown in [Table 1](#molecules-22-00842-t001){ref-type="table"}. HR-ESI-MS *m/z*: 359.1873 (C~21~H~27~O~5~^+^, \[M + H\]^+^, calc. 359.1858).

3.4. Anti-Inflammatory Assay {#sec3dot4-molecules-22-00842}
----------------------------

The anti-inflammatory activities of compounds **1** to **3** were evaluated using LPS-induced RAW 264.7 cells. RAW 264.7 macrophages cells (8 × 10^4^ cells/well) were suspended in 100 µL of DMEM supplemented with 10% fetal bovine serum, and precultured in 96-well microplates and 5% CO~2~ in air for 12 h at 37 °C, then test compounds (50 µmol/L) were cultured, and were treated with or without 1 µg/mL LPS for 24 h. NO production in each well was assessed by measuring the accumulation of nitrite in the culture medium using Griess reagent. Cytotoxicity was determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2*H*-tetrazolium bromide (MTT) colorimetric assay. Briefly, after 24 h incubation with test compounds, MTT (20 µL, 5 mg/mL in PBS) solution was added to the wells. After 4 h of culturing, the medium was removed and DMSO 100 µL/well was then added to dissolve the formazan produced in the cells. The optical density of the formazan solution was measured with a microplate reader at 490 nm. Z,Z'-6,6',7,3'α-diligustilide was used as positive control. Each test compound was dissolved in dimethyl sulfoxide (DMSO), and the solution was added to the medium (final DMSO concentration was 0.1%). MTT experiments were repeated three times. The NO inhibitory ratio (%) was calculated by the following formula:
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molecules-22-00842-t001_Table 1

###### 

^1^H- (600 MH~Z~) and ^13^C-NMR (150 MH~Z~) data of compounds **1**--**3** (CDCl~3~).

  No.     1               2       3                                                     
  ------- --------------- ------- ---------------- ------- ---------------------------- -------
  1α      1.37 (m)        38.9    1.38 (t, 12.8)   38.9    1.39 (ddd, 3.5, 9.9, 13.5)   38.6
  1β      2.30 (m)                2.28 (d, 12.8)           2.33 (d, 13.5)               
  2α      1.70 (m)        19.3    1.69 (d, 11.7)   19.3    1.73 (m)                     19.2
  2β      2.06 (m)                2.05 (m)                 2.12 (m)                     
  3α      1.13 (m)        32.0    1.12 (m)         32.0    1.19 (dd, 4.6, 13.5)         32.0
  3β      2.45 (d, 9.3)           2.45 (d, 11.7)           2.40 (d, 13.5)               
  4                       49.9                     49.9                                 47.9
  5       1.69 (m)        47.7    1.69 (d, 11.9)   47.7    1.78 (d, 12.3)               47.6
  6α      2.02 (m)        20.8    2.02 (m)         20.8    2.03 (dd, 5.4, 13.5)         20.8
  6β      2.10 (m)                2.08 (m)                 2.15 (m)                     
  7α      2.80 (m)        31.6    2.78 (m)         31.5    2.84 (m)                     31.5
  7β      2.87 (m)                2.85 (m)                 2.97 (dd, 4.7, 16.8)         
  8                       134.7                    134.7                                135.4
  9                       147.2                    145.3                                153.3
  10                      38.2                     38.1                                 39.0
  11      7.21 (d, 8.2)   125.3   7.17 (d, 8.3)    125.3   7.35 (d, 8.5)                125.9
  12      8.25 (d, 8.2)   123.1   6.99 (d, 8.3)    124.1   7.71 (dd, 1.5, 8.5)          126.0
  13                      138.3                    145.8                                134.8
  14      7.12 (s)        126.0   6.87 (s)         126.8   7.65 (d, 1.5)                129.5
  15                      142.9   2.82 (m)         33.4                                 198.3
  16*a*   5.02 (s)        111.7   1.21 (s)         24.0                                 
  16*b*   5.32 (s)                                                                      
  17      2.11 (s)        21.7    1.22 (s)         24.0    2.56 (s)                     26.7
  18*a*   3.48 (d, 5.9)   71.4    3.48 (d, 9.4)    71.5    4.10 (d, 10.4)               71.6
  18*b*   4.16 (d, 5.9)           4.16 (d, 9.4)            4.49 (d, 10.4)               
  19                      181.1                    181.1                                180.3
  20      1.16 (s)        23.4    1.15 (s)         23.5    1.17 (s)                     23.1
  21                                                                                    171.0
  22                                                       2.06 (s)                     20.9

molecules-22-00842-t002_Table 2

###### 

Anti-inflammatory effects of compounds **1**--**3** from *Callicarpa macrophylla* Vahl. on LPS-induced RAW264.7 macrophages.

  Compound                             Conc. (μM)   NO Inhibitory Rate (%)   Cell Viability (%)
  ------------------------------------ ------------ ------------------------ --------------------
  **1**                                50           37.89 ± 3.28 ^a^         94.26 ± 7.78
  **2**                                50           34.47 ± 4.35 ^a^         93.58 ± 2.16
  **3**                                50           40.13 ± 2.45 ^a^         94.76 ± 3.91
  Z, Z'-6,6',7,3'α-Diligustilide ^b^   50           69.37 ± 6.08 ^a^         108.50 ± 1.90

^a^ The three compounds were tested in the same value as 50 μM. ^b^ *p* \< 0.01, significantly different from LPS model group. Data were presented as mean ± SD of three independent experiments.
